Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$0.54 - $2.74 $126,252 - $640,612
-233,800 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.33 - $3.37 $8,854 - $12,806
-3,800 Reduced 1.6%
233,800 $624,000
Q3 2021

Nov 08, 2021

SELL
$2.52 - $2.99 $3,780 - $4,485
-1,500 Reduced 0.63%
237,600 $656,000
Q2 2021

Aug 09, 2021

BUY
$2.6 - $3.65 $245,700 - $344,925
94,500 Added 65.35%
239,100 $681,000
Q1 2021

May 13, 2021

BUY
$2.73 - $4.5 $22,113 - $36,450
8,100 Added 5.93%
144,600 $496,000
Q4 2020

Feb 09, 2021

SELL
$2.6 - $3.32 $5,200 - $6,640
-2,000 Reduced 1.44%
136,500 $360,000
Q3 2020

Nov 09, 2020

BUY
$2.46 - $4.27 $62,976 - $109,311
25,600 Added 22.67%
138,500 $432,000
Q2 2020

Aug 12, 2020

SELL
$1.45 - $4.3 $85,840 - $254,560
-59,200 Reduced 34.4%
112,900 $467,000
Q1 2020

May 04, 2020

SELL
$0.75 - $2.55 $43,725 - $148,665
-58,300 Reduced 25.3%
172,100 $277,000
Q4 2019

Feb 12, 2020

BUY
$1.65 - $2.48 $132,330 - $198,896
80,200 Added 53.4%
230,400 $572,000
Q3 2019

Nov 12, 2019

SELL
$1.48 - $2.52 $2,220 - $3,780
-1,500 Reduced 0.99%
150,200 $253,000
Q2 2019

Aug 16, 2019

SELL
$2.45 - $3.32 $3,430 - $4,648
-1,400 Reduced 0.91%
151,700 $379,000
Q1 2019

May 13, 2019

BUY
$2.52 - $3.24 $22,680 - $29,160
9,000 Added 6.25%
153,100 $470,000
Q4 2018

Feb 05, 2019

SELL
$1.92 - $4.1 $27,840 - $59,449
-14,500 Reduced 9.14%
144,100 $380,000
Q3 2018

Nov 07, 2018

SELL
$3.39 - $4.61 $38,646 - $52,554
-11,400 Reduced 6.71%
158,600 $684,000
Q2 2018

Aug 10, 2018

SELL
$1.89 - $4.95 $69,174 - $181,170
-36,600 Reduced 17.72%
170,000 $670,000
Q1 2018

May 08, 2018

BUY
$2.06 - $2.38 $10,094 - $11,662
4,900 Added 2.43%
206,600 $428,000
Q3 2017

Nov 07, 2017

BUY
$2.44 - $2.91 $2,684 - $3,201
1,100 Added 0.55%
201,700 $540,000
Q2 2017

Nov 20, 2017

BUY
N/A
200,600
200,600 $480,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $318M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.